المؤلفون: Hope, Jennifer, Stairiker, Christopher, Spantidea, Panagiota, Gracias, DT, Carey, AJ, Fike, AJ, van Meurs, Marjan, Brouwers - Haspels, Inge, Rijsbergen, Laurine, Fraietta, JA, Müller, Yvonne, Klop, Roos, Stelekati, E, Wherry, EJ, Erkeland, Stefan, Katsikis, Peter

المصدر: Hope , J , Stairiker , C , Spantidea , P , Gracias , DT , Carey , AJ , Fike , AJ , van Meurs , M , Brouwers - Haspels , I , Rijsbergen , L , Fraietta , JA , Müller , Y , Klop , R , Stelekati , E , Wherry , EJ , Erkeland , S & Katsikis , P 2017 , ' The Transcription Factor T-Bet Is Regulated by MicroRNA-155 in Murine Anti-Viral CD8+T Cells via SHIP-1 ' , Frontiers in Immunology , vol. 8 , 1696 .

مصطلحات الفهرس: dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM027202; name=EMC MM-02-72-02, article

URL: https://pure.eur.nl/en/publications/56704f74-de83-4ed3-a219-0d735095b4f6

المؤلفون: Bhagwat AS; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Torres L; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Immunology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Shestova O; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Shestov M; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Mellors PW; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Fisher HR; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Farooki SN; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Frost BF; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Loken MR; Hematologics Inc., Seattle, WA, USA., Gaymon AL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Frazee D; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Rogal W; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Frey N; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Hexner EO; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Luger SM; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Loren AW; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Martin ME; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., McCurdy SR; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Perl AE; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Stadtmauer EA; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Brogdon JL; Novartis Biomedical Research, Cambridge, MA, USA., Fraietta JA; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Hwang WT; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA., Siegel DL; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA., Plesa G; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA., Aplenc R; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Porter DL; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., June CH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA., Gill SI; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. saar.gill2@pennmedicine.upenn.edu.; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA. saar.gill2@pennmedicine.upenn.edu.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA. saar.gill2@pennmedicine.upenn.edu.

المصدر: Nature medicine [Nat Med] 2024 Sep 27. Date of Electronic Publication: 2024 Sep 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

المؤلفون: Chang JF; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.; Center for Gene and Cellular Immunotherapy, Washington University School of Medicine, St. Louis, Missouri., Wellhausen N; Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.; Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania., Engel NW; Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.; Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania., Landmann JH; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.; Center for Gene and Cellular Immunotherapy, Washington University School of Medicine, St. Louis, Missouri., Hopkins CR; Deparment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.; Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania., Salas-McKee J; Deparment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.; Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania., Bear AS; Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.; Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania., Selli ME; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.; Center for Gene and Cellular Immunotherapy, Washington University School of Medicine, St. Louis, Missouri., Agarwal S; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.; Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania., Jadlowsky JK; Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania., Linette GP; Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.; Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania., Gill S; Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.; Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania., June CH; Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.; Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania., Fraietta JA; Deparment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.; Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania., Singh N; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.; Center for Gene and Cellular Immunotherapy, Washington University School of Medicine, St. Louis, Missouri.

المصدر: Cancer immunology research [Cancer Immunol Res] 2024 Sep 03; Vol. 12 (9), pp. 1136-1146.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

مواضيع طبية MeSH: Gene Editing*/methods , T-Lymphocytes*/immunology , T-Lymphocytes*/metabolism, Humans ; CRISPR-Cas Systems ; Receptors, Antigen, T-Cell/genetics ; Receptors, Antigen, T-Cell/immunology

المؤلفون: Jadlowsky JK; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania., Chang JF; Center for Gene and Cellular Immunotherapy, Washington University School of Medicine, St. Louis, Missouri.; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri., Spencer DH; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri., Warrington JM; Center for Gene and Cellular Immunotherapy, Washington University School of Medicine, St. Louis, Missouri.; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri., Levine BL; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., June CH; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Fraietta JA; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania., Singh N; Center for Gene and Cellular Immunotherapy, Washington University School of Medicine, St. Louis, Missouri.; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.

المصدر: Cancer immunology research [Cancer Immunol Res] 2024 Sep 03; Vol. 12 (9), pp. 1132-1135.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

مواضيع طبية MeSH: Gene Editing* , T-Lymphocytes*/immunology , T-Lymphocytes*/metabolism, Humans ; Genetic Therapy/methods ; Immunotherapy, Adoptive/methods ; Animals ; Receptors, Chimeric Antigen/genetics ; Receptors, Chimeric Antigen/immunology ; CRISPR-Cas Systems ; Receptors, Antigen, T-Cell/genetics ; Cell- and Tissue-Based Therapy/methods

المؤلفون: Li N; Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Rodriguez JL; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Yin Y; Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Logun MT; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Zhang L; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Yu S; Department of Neurosurgery, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing 211800, China., Hicks KA; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Zhang JV; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Zhang L; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Xie C; Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China., Wang J; Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China., Wang T; Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China., Xu J; Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China., Fraietta JA; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Binder ZA; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA., Lin Z; Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China. Electronic address: linzhiguo@hotmail.com., O'Rourke DM; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. Electronic address: donald.orourke@pennmedicine.upenn.edu.

المصدر: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Jul 31. Date of Electronic Publication: 2024 Jul 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE

المؤلفون: Pan H, Liu Y, Fuller AM, Williams EF, Fraietta JA, Eisinger TSK

المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2024 Jul 02. Date of Electronic Publication: 2024 Jul 02.

نوع المنشور: Journal Article; Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

المؤلفون: Chong EA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: Elise.Chong@pennmedicine.upenn.edu., Chong ER; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Therwhanger D; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Nasta SD; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Landsburg DJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Barta SK; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Svoboda J; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Gerson JN; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Ghilardi G; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Paruzzo L; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Fraietta JA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Weber E; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Stefano N; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Porter DL; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Frey NV; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Garfall AL; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Ruella M; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Jul; Vol. 30 (7), pp. 726.e1-726.e8. Date of Electronic Publication: 2024 Mar 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Bendamustine Hydrochloride*/therapeutic use , Bendamustine Hydrochloride*/administration & dosage , Lymphoma, Mantle-Cell*/drug therapy , Immunotherapy, Adoptive*/methods, Humans ; Male ; Female ; Middle Aged ; Aged ; Retrospective Studies ; Vidarabine/analogs & derivatives ; Vidarabine/therapeutic use ; Vidarabine/administration & dosage ; Adult ; Antineoplastic Agents, Alkylating/therapeutic use ; Antineoplastic Agents, Alkylating/administration & dosage ; Antigens, CD19/immunology ; Treatment Outcome

المؤلفون: Myers RM; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Devine K; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Li Y; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Lawrence S; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA., Leahy AB; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Liu H; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA., Vernau L; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA., Callahan C; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA., Baniewicz D; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA., Kadauke S; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., McGuire R; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA., Wertheim GB; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Kulikovskaya I; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Gonzalez VE; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Fraietta JA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., DiNofia AM; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Hunger SP; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Rheingold SR; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Aplenc R; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., June CH; Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Grupp SA; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Wray L; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Maude SL; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

المصدر: Blood advances [Blood Adv] 2024 May 14; Vol. 8 (9), pp. 2182-2192.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, CD19*/immunology , Antigens, CD19*/therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy , Immunotherapy, Adoptive*/methods , Immunotherapy, Adoptive*/adverse effects, Humans ; Child ; Child, Preschool ; Female ; Male ; Receptors, Chimeric Antigen/therapeutic use ; Adolescent ; Recurrence ; Retrospective Studies ; Infant ; Receptors, Antigen, T-Cell/therapeutic use ; Treatment Outcome ; T-Lymphocytes/immunology

المؤلفون: Bagley SJ; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. sbagley@pennmedicine.upenn.edu.; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. sbagley@pennmedicine.upenn.edu., Logun M; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Fraietta JA; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Wang X; Department of Neuroscience, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Desai AS; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Bagley LJ; Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Nabavizadeh A; Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Jarocha D; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Martins R; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Maloney E; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Lledo L; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Stein C; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Marshall A; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Leskowitz R; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Jadlowsky JK; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Christensen S; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Oner BS; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Plesa G; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Brennan A; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Gonzalez V; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Chen F; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Sun Y; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Neuroscience, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Gladney W; Kite Pharma, a Gilead Company, Santa Monica, CA, USA., Barrett D; Kite Pharma, a Gilead Company, Santa Monica, CA, USA., Nasrallah MP; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Hwang WT; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Ming GL; Department of Neuroscience, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Institute for Regenerative Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Song H; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Neuroscience, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Institute for Regenerative Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Siegel DL; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., June CH; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Hexner EO; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Binder ZA; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., O'Rourke DM; Glioblastoma Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. donald.orourke@pennmedicine.upenn.edu.; Department of Neurosurgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. donald.orourke@pennmedicine.upenn.edu.; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. donald.orourke@pennmedicine.upenn.edu.

المصدر: Nature medicine [Nat Med] 2024 May; Vol. 30 (5), pp. 1320-1329. Date of Electronic Publication: 2024 Mar 13.

نوع المنشور: Journal Article; Clinical Trial, Phase I

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Glioblastoma*/therapy , Glioblastoma*/immunology , Glioblastoma*/diagnostic imaging , Glioblastoma*/pathology , Interleukin-13 Receptor alpha2 Subunit*/immunology , Receptors, Chimeric Antigen*/immunology , ErbB Receptors* , Immunotherapy, Adoptive*/adverse effects , Immunotherapy, Adoptive*/methods, Humans ; Middle Aged ; Male ; Female ; Neoplasm Recurrence, Local/immunology ; Neoplasm Recurrence, Local/pathology ; Adult ; Aged ; Brain Neoplasms/immunology ; Brain Neoplasms/therapy ; Brain Neoplasms/pathology ; Injections, Spinal ; Maximum Tolerated Dose

المؤلفون: Doan AE; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Mueller KP; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Chen AY; Department of Pathology, Stanford University, Stanford, CA, USA.; Department of Bioengineering, Stanford University, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Rouin GT; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Chen Y; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Daniel B; Department of Pathology, Stanford University, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA, USA.; Department of Genetics, Stanford University, Stanford, CA, USA.; Genentech, South San Francisco, CA, USA., Lattin J; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Markovska M; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Mozarsky B; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Arias-Umana J; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Hapke R; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Jung IY; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wang A; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Xu P; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Klysz D; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Zuern G; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Bashti M; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Quinn PJ; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Miao Z; Department of Genetics, Stanford University, Stanford, CA, USA., Sandor K; Department of Pathology, Stanford University, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Zhang W; Department of Pathology, Stanford University, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Chen GM; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Ryu F; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Logun M; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Hall J; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Tan K; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Grupp SA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., McClory SE; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Lareau CA; Department of Pathology, Stanford University, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Fraietta JA; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Sotillo E; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Satpathy AT; Department of Pathology, Stanford University, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. cmackall@stanford.edu.; Department of Pediatrics, Stanford University, Stanford, CA, USA. cmackall@stanford.edu.; Department of Medicine, Stanford University, Stanford, CA, USA. cmackall@stanford.edu., Weber EW; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. weberew@chop.edu.; Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA. weberew@chop.edu.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. weberew@chop.edu.; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA. weberew@chop.edu.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. weberew@chop.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. weberew@chop.edu.

المصدر: Nature [Nature] 2024 May; Vol. 629 (8011), pp. E11.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: PubMed not MEDLINE; MEDLINE